- Previous Close
2.1200 - Open
1.9900 - Bid 2.0600 x --
- Ask 2.3200 x --
- Day's Range
1.8000 - 2.5800 - 52 Week Range
1.3010 - 49.2000 - Volume
275,100 - Avg. Volume
49,338 - Market Cap (intraday)
16.381M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-524.4700 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo.Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus. Its biomarkers include C-reactive protein, PHE/Phenylalanine for PKU patients, and Sars-CoV-2/Influenza multiplex tests. The company was incorporated in 2019 and is based in Helsingborg, Sweden.
www.qlifeholding.comRecent News: QLIFE.ST
View MorePerformance Overview: QLIFE.ST
Trailing total returns as of 1/15/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: QLIFE.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: QLIFE.ST
View MoreValuation Measures
Market Cap
14.97M
Enterprise Value
20.53M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
71.41k
Price/Book (mrq)
74.84
Enterprise Value/Revenue
297.51
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-36.23%
Return on Equity (ttm)
-351.05%
Revenue (ttm)
69k
Net Income Avi to Common (ttm)
-160.96M
Diluted EPS (ttm)
-524.4700
Balance Sheet and Cash Flow
Total Cash (mrq)
3.07M
Total Debt/Equity (mrq)
4,334.67%
Levered Free Cash Flow (ttm)
-59.41M